Methyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 100mg

terc-butilmetiléter, mínimo 99,5 %, para síntesis, 10 l, blister blanco

N2-(1-(5-Amino-1,3,4-thiadiazol-2-yl)piperidin-4-yl)-1,3,4-thiadiazole-2,5-diamine, 250mg

Lithium metaborate, 98.0%, 100g

2,2',4,4'-Tetrahydroxybenzophenone>98.0%(HPLC)25g

1-(2,2-Difluoroethyl)-1H-pyrazol-4-amine, 97%, 5g

3,6-Dichloropyrazine-2-carboxylic acid, 95.0%, 100mg

3-(Trifluoromethoxy)benzenethiol, 97%, 100mg

(S)-3-Cyclohexyl-2-hydroxypropanoic acid, 98%, 250mg

tert-Butyl (2S,4R)-4-((tert-butyldimethylsilyl)oxy)-2-formylpyrrolidine-1-carboxylate, 98%, 100mg

1,4-DIOXASPIRO[4.5]DECAN-8-AMINE, 95.0%, 10g

Estándar de densidad, ROTI®Calipure, 1,7470 g/ml (20 °C), 100 ml, envase de vidrio

Ethyl 2-(2-bromo-5-methylthiazol-4-yl)acetate, 1g